Assyro AI

Orange Book product · Brand (NDA)

LUZU

LULICONAZOLE

Brand (NDA)NDA 204153RX BAUSCH

At a glance

Nov 14, 2013

Approved

Brand (NDA)

Application

Not listed

TE code

4

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 14, 2013

    12 yr 9 mo ago

  2. Today

  3. Patent 9012484 expires

    Listed drug substance patent expiration.

    Sep 06, 2033

    in 7 yr 4 mo

  4. Patent 9199977 expires

    Listed drug substance patent expiration.

    Sep 06, 2033

    in 7 yr 4 mo

  5. Patent 9453006 expires

    Listed drug substance patent expiration.

    Sep 06, 2033

    in 7 yr 4 mo

  6. Patent 8980931 expires

    Listed drug product patent expiration.

    Apr 28, 2034

    in 8 yr

Pharmaceutical detail

Active ingredient

LULICONAZOLE

Strength

1%

Dosage form

CREAM

Route

TOPICAL

TE code

Not listed

Application

NDA 204153

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (4)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9012484Sep 06, 2033in 7 yr 4 mo
SubstanceProductU-540
9199977Sep 06, 2033in 7 yr 4 mo
SubstanceProduct
9453006Sep 06, 2033in 7 yr 4 mo
Substance
8980931Apr 28, 2034in 8 yr
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.